Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3873
-0.0354-8.37%
Last update: Oct 2, 7:55 PM
$0.3825
-0.0402-9.51%
Enlivex Ltd (ENLV) Stock Price, Quote, News & History
ENLVNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Enlivex (NASDAQ:ENLV) through any online brokerage.
Other companies in Enlivex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Enlivex has a consensus price target of $137.50.
The stock price for Enlivex (NASDAQ: ENLV) is $0.3825 last updated October 2, 2026 at 7:55 PM EDT.
There are no upcoming dividends for Enlivex.
Enlivex does not have any upcoming earnings scheduled.
There is no upcoming split for Enlivex.
Enlivex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
